Hydrocephalus medical therapy

Hydrocephalus Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology & Demographics
Risk Factors
Screening
Natural History, Complications & Prognosis
Diagnosis
Diagnostic Study of Choice
History & Symptoms
Physical Examination
Electrocardiogram
X-ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hydrocephalus medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hydrocephalus medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
National Guidelines Clearinghouse
NICE Guidance
FDA on Hydrocephalus medical therapy
CDC on Hydrocephalus medical therapy
Hydrocephalus medical therapy in the news
Blogs onHydrocephalus medical therapy
Directions to Hospitals Treating Hydrocephalus
Risk calculators and risk factors for Hydrocephalus medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun M.D., PhD.,Kalsang Dolma, M.B.B.S.[2]

Medical Therapy

Carbonic anhydrase inhibitor: Acetazolamide may provide temporary releif by reducing the rate of CSF production, but long term results are disappointing.

Diuretics:Furosemide can be used as an adjunctive therapy with acetazolamide.